Intramyocardial Injection
Showing 1 - 25 of >10,000
Coronary Artery Disease Trial in Houston (Stem Cell Therapy, Control (plasma))
Active, not recruiting
- Coronary Artery Disease
- Stem Cell Therapy
- Control (plasma)
-
Houston, TexasTexas Heart Institute/Baylor St. Luke's Medical Center
Apr 25, 2022
Hypoplastic Left Heart Syndrome Trial in United States (Autologous (self) mononuclear cells derived from umbilical cord blood,
Active, not recruiting
- Hypoplastic Left Heart Syndrome
- Autologous (self) mononuclear cells derived from umbilical cord blood
- Stage II Surgical repair
-
Birmingham, Alabama
- +7 more
Jan 9, 2023
Chronic Myocardial Ischemia Trial in France (Autologous MSC from bone marrow, Placebo comparator)
Recruiting
- Chronic Myocardial Ischemia
- Autologous MSC from bone marrow
- Placebo comparator
-
Créteil, France
- +5 more
Oct 27, 2021
Myocardial Fibrosis Trial (iMP cells, Control injection)
Unknown status
- Myocardial Fibrosis
- iMP cells
- Control injection
- (no location specified)
Jan 24, 2020
Chronic Myocardial Ischemia Trial in Monza, Milano, Torino (Autologous bone marrow derived-CD133+ cells)
Completed
- Chronic Myocardial Ischemia
- Autologous bone marrow derived-CD133+ cells
-
Monza, MB, Italy
- +2 more
Mar 21, 2022
Heart Failure Trial in Saint-Petersburg (NOGA XP Cardiac Navigation System)
Terminated
- Heart Failure
- NOGA XP Cardiac Navigation System
-
Saint-Petersburg, Russian FederationAlmazov Federal National Medical Research Centre
Feb 11, 2020
Heart Failure, Cardiomyopathy, Ventricular Dysfunction Trial in Canada, United States (MPC Intramyocardial Injection, Control
Completed
- Heart Failure
- +2 more
- MPC Intramyocardial Injection
- Control Solution
-
Los Angeles, California
- +18 more
Nov 7, 2019
HLHS Trial in United States (Longeveron Mesenchymal Stem Cells)
Completed
- HLHS
- Longeveron Mesenchymal Stem Cells
-
Atlanta, Georgia
- +4 more
Mar 4, 2022
Hypoplastic Left Heart Syndrome Trial in Baltimore (Allo-hMSCs, Placebo)
Terminated
- Hypoplastic Left Heart Syndrome
- Allo-hMSCs
- Placebo
-
Baltimore, Maryland
- +1 more
Jul 13, 2021
Chronic Ischemic Heart Disease, Coronary Artery Disease, Angina Pectoris Trial in Sao Paulo (Cell Therapy)
Completed
- Chronic Ischemic Heart Disease
- +2 more
- Cell Therapy
-
Sao Paulo, SP, BrazilHeart Institute
Aug 28, 2019
Heart Failure Trial in Minneapolis (Intramyocardial Delivery of Bone Marrow Derived Mononuclear Cells)
Completed
- Heart Failure
- Intramyocardial Delivery of Bone Marrow Derived Mononuclear Cells
-
Minneapolis, MinnesotaUniversity Of Minnesota
Feb 27, 2020
Myocardial Ischemia Trial in United States (CLBS14 (low-dose), CLBS14 (high-dose), injection)
Completed
- Myocardial Ischemia
- CLBS14 (low-dose)
- +2 more
-
Birmingham, Alabama
- +25 more
Jan 8, 2021
CHF Trial in United States (Intramyocardial injection of bone marrow mononuclear cells, Intramyocardial injection of CD34+
Terminated
- Heart Failure, Congestive
- Intramyocardial injection of bone marrow mononuclear cells
- +2 more
-
Oak Lawn, Illinois
- +6 more
Mar 28, 2019
Stem Cell Transplantation, Ventricular Dysfunction, Left Trial in Miami, Baltimore (Lower dose mesenchymal stem cell (MSC)
Terminated
- Stem Cell Transplantation
- Ventricular Dysfunction, Left
- Lower dose mesenchymal stem cell (MSC) injection
- +2 more
-
Miami, Florida
- +1 more
Aug 19, 2019
Aortic Valve Stenosis Trial in Brest (18F-FDG PET-CT)
Not yet recruiting
- Aortic Valve Stenosis
- 18F-FDG PET-CT
-
Brest, FranceCHU de Brest
Mar 24, 2022
ST Elevation Myocardial Infarction Trial in Bucheon (Repatha®)
Recruiting
- ST Elevation Myocardial Infarction
-
Bucheon, Korea, Republic ofSejong General Hospital
Oct 10, 2023
Hypoplastic Left Heart Syndrome Trial in Atlanta, Baltimore, Ann Arbor (c-kit+ cells)
Recruiting
- Hypoplastic Left Heart Syndrome
- c-kit+ cells
-
Atlanta, Georgia
- +2 more
Oct 5, 2021
Hypoplastic Left Heart Syndrome Trial in United States (Lomecel-B medicinal signaling cells)
Recruiting
- Hypoplastic Left Heart Syndrome
- Lomecel-B medicinal signaling cells
-
Los Angeles, California
- +6 more
Aug 10, 2022
Heart Failure Trial in Copenhagen Ø (Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC), Placebo)
Completed
- Heart Failure
- Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC)
- Placebo
-
Copenhagen Ø, DenmarkCardiac Catheterization Laboratory 2014, The Heart Centre, Unive
Sep 2, 2022
Heart Failure Trial in Hamburg (autologous CD133pos stem cell application)
Terminated
- Heart Failure
- autologous CD133pos stem cell application
-
Hamburg, GermanyASKLEPIOS Klinik St. Georg
Aug 20, 2021
Myocardial Ischemia, Coronary Artery Disease Trial in Germany (CD133+ autologous bone marrow stem cell, Placebo)
Terminated
- Myocardial Ischemia
- Coronary Artery Disease
- CD133+ autologous bone marrow stem cell
- Placebo
-
Bad Oeynhausen, Germany
- +5 more
Jul 13, 2020
Acute Myocardial Infarction Trial in Indianapolis
Recruiting
- Acute Myocardial Infarction
-
Indianapolis, IndianaIU Methodist Hospital
Jun 1, 2023
Heart Failure Trial in United States (Mesenchymal Precursor cells (RevascorTM), Cryoprotective media alone)
Terminated
- Heart Failure
- Mesenchymal Precursor cells (RevascorTM)
- Cryoprotective media alone
-
San Diego, California
- +16 more
Feb 28, 2019
Ischemic Heart Disease, Bone Marrow Cells, Coronary Artery Bypass Grafting (CABG) Trial in St. Petersburg (Group 1, Group 0,
Completed
- Ischemic Heart Disease
- +3 more
- Group 1
- +2 more
-
St. Petersburg, Russian FederationFirst Pavlov State Medical University of St. Petersburg
May 20, 2021
Liwen Procedure in Obstructive Hypertrophic Cardiomyopathy on
Active, not recruiting
- Hypertrophic Cardiomyopathy
- Arrhythmia
- Percutaneous Intramyocardial Septal Radiofrequency Ablation for hypertrophic obstructive cardiomyopathy (Liwen Procedure)
-
Xi'an, Shaanxi, ChinaUltrasound Medicine Department of Xijing Hospital, Fourth Milita
Sep 4, 2023